X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10885) 10885
Newsletter (376) 376
Magazine Article (65) 65
Newspaper Article (57) 57
Book Chapter (36) 36
Dissertation (29) 29
Publication (24) 24
Book Review (4) 4
Government Document (4) 4
Web Resource (4) 4
Conference Proceeding (3) 3
Journal / eJournal (3) 3
Paper (3) 3
Transcript (3) 3
Book / eBook (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
azithromycin (8066) 8066
humans (6348) 6348
female (3294) 3294
male (3283) 3283
anti-bacterial agents - therapeutic use (2775) 2775
azithromycin - therapeutic use (2503) 2503
infectious diseases (2236) 2236
adult (2083) 2083
microbiology (1982) 1982
pharmacology & pharmacy (1940) 1940
antibiotics (1780) 1780
anti-bacterial agents - pharmacology (1583) 1583
middle aged (1498) 1498
azithromycin - pharmacology (1290) 1290
animals (1224) 1224
azithromycin - administration & dosage (1198) 1198
anti-bacterial agents - administration & dosage (1173) 1173
microbial sensitivity tests (1132) 1132
erythromycin (1131) 1131
clarithromycin (1129) 1129
treatment outcome (1127) 1127
adolescent (1091) 1091
infections (1068) 1068
research (1030) 1030
child (1025) 1025
immunology (978) 978
infection (968) 968
aged (946) 946
macrolides (832) 832
children (822) 822
medicine, general & internal (815) 815
health aspects (792) 792
drug therapy (786) 786
child, preschool (760) 760
care and treatment (712) 712
risk factors (650) 650
analysis (641) 641
anti-bacterial agents - adverse effects (625) 625
infant (614) 614
therapy (612) 612
prevalence (593) 593
pharmacokinetics (591) 591
drug resistance, bacterial (585) 585
azithromycin - adverse effects (574) 574
respiratory system (568) 568
resistance (564) 564
drug resistance (558) 558
dosage and administration (555) 555
pediatrics (547) 547
young adult (547) 547
ciprofloxacin (533) 533
antimicrobial resistance (520) 520
pneumonia (492) 492
diagnosis (491) 491
prevention (491) 491
bacteria (489) 489
drug therapy, combination (488) 488
susceptibility (484) 484
efficacy (480) 480
antimicrobial agents (468) 468
epidemiology (462) 462
abridged index medicus (458) 458
research article (457) 457
doxycycline (456) 456
mice (454) 454
administration, oral (445) 445
disease (431) 431
inflammation (425) 425
macrolide antibiotics (423) 423
chlamydia trachomatis (415) 415
anti-bacterial agents - pharmacokinetics (413) 413
chlamydia infections - drug therapy (397) 397
erythromycin - pharmacology (397) 397
macrolide (397) 397
drug administration schedule (393) 393
time factors (390) 390
double-blind (382) 382
medicine (382) 382
clinical trials (379) 379
retrospective studies (378) 378
in-vitro (370) 370
mortality (364) 364
ceftriaxone (359) 359
cystic fibrosis (357) 357
medical research (356) 356
azithromycin - pharmacokinetics (354) 354
trachoma (344) 344
drug resistance in microorganisms (343) 343
ophthalmology (340) 340
pregnancy (339) 339
prospective studies (339) 339
usage (329) 329
double-blind method (324) 324
dose-response relationship, drug (322) 322
chlamydia (318) 318
aged, 80 and over (316) 316
drugs (314) 314
follow-up studies (311) 311
patients (311) 311
erythromycin - analogs & derivatives (307) 307
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10688) 10688
French (200) 200
Japanese (139) 139
Spanish (131) 131
German (116) 116
Russian (88) 88
Chinese (72) 72
Portuguese (38) 38
Italian (30) 30
Croatian (24) 24
Polish (22) 22
Korean (18) 18
Turkish (17) 17
Bulgarian (8) 8
Czech (7) 7
Danish (6) 6
Persian (6) 6
Dutch (5) 5
Norwegian (5) 5
Romanian (4) 4
Hungarian (3) 3
Finnish (2) 2
Hebrew (2) 2
Icelandic (2) 2
Slovak (2) 2
Swedish (2) 2
Ukrainian (2) 2
Arabic (1) 1
Bosnian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2018, Volume 2018, Issue 10, p. CD009764
Background There has been renewal of interest in the use of prophylactic antibiotics to reduce the frequency of exacerbations and improve quality of life in... 
Fluoroquinolones | Quinolines | Clarithromycin | Lungs & airways | Drug Administration Schedule | Pulmonary Disease, Chronic Obstructive | Azithromycin | Antibiotic Prophylaxis | Roxithromycin | Erythromycin | Moxifloxacin | Disease Progression | Randomized Controlled Trials as Topic | Trimethoprim, Sulfamethoxazole Drug Combination | Chronic obstructive pulmonary disease (stable) | Amoxicillin | Anti‐Bacterial Agents | Aza Compounds | Clavulanic Acid | Quality of Life | Chronic obstructive pulmonary disease, stable ‐ pharmacotherapy | Medicine General & Introductory Medical Sciences | Other medications | Azithromycin [therapeutic use] | STABLE COPD | Humans | AIRWAY INFLAMMATION | Quinolines [therapeutic use] | Anti-Bacterial Agents [therapeutic use] | MEDICINE, GENERAL & INTERNAL | DAILY PENICILLIN | Aza Compounds [therapeutic use] | TETRACYCLINE | Erythromycin [therapeutic use] | CHRONIC-BRONCHITIS | LONG-TERM AZITHROMYCIN | Antibiotic Prophylaxis [methods] | Pulmonary Disease, Chronic Obstructive [drug therapy] | ACUTE EXACERBATIONS | INDUCED SPUTUM | Clarithromycin [therapeutic use] | DOUBLE-BLIND | Aged | HEALTH-STATUS | Aza Compounds - therapeutic use | Anti-Bacterial Agents - therapeutic use | Anti-Bacterial Agents - adverse effects | Roxithromycin - adverse effects | Roxithromycin - therapeutic use | Antibiotic Prophylaxis - methods | Clarithromycin - therapeutic use | Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Erythromycin - therapeutic use | Clavulanic Acid - adverse effects | Clavulanic Acid - therapeutic use | Azithromycin - adverse effects | Moxifloxacin - therapeutic use | Azithromycin - therapeutic use | Amoxicillin - therapeutic use | Amoxicillin - adverse effects | Quinolines - therapeutic use | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Drug design, development and therapy, ISSN 1177-8881, 2018, Volume 12, pp. 3855 - 3866
Background: The obnoxious bitter taste of orally taken antibiotics is one of the biggest problems in the treatment of children. The pediatric population cannot... 
Azithromycin–TiO2 nanohybrid | AZN | Azithromycin | TNPs | Dissolution | Physisorption | Titanium dioxide nanoparticles | CHEMISTRY, MEDICINAL | STABILITY | titanium dioxide nanoparticles | dissolution | NANOCRYSTALS | azithromycin | physisorption | FORMULATION | ADSORPTION | SOLUBILITY | NANOPARTICLES | IN-VITRO | azithromycin-TiOnanohybrid | ERYTHROMYCIN | PHARMACOLOGY & PHARMACY | OPTIMIZATION | FABRICATION | Azithromycin - chemistry | Titanium - pharmacology | Nanoparticles - chemistry | Humans | Molecular Conformation | Titanium - chemistry | Healthy Volunteers | Azithromycin - pharmacology | Particle Size | Taste - drug effects | Adsorption | Anti-Bacterial Agents - chemistry | Surface Properties | Anti-Bacterial Agents - pharmacology | Titanium | Health aspects | Titanium dioxide | Analysis | Fourier transforms | Adsorbates | X-ray diffraction | Dosage | Adsorbents | Nanoparticles | Aqueous solutions | Masking | Children | Psychological stress | Scanning electron microscopy | Stability | X ray powder diffraction | Bitter taste | Accelerated tests | Environmental factors | Liquid chromatography | High-performance liquid chromatography | Pharynx | Dispersion | Studies | Organic chemistry | Palatability | Antibiotics | Taste | Drying | Pediatrics | Particle size | Efficiency | Drug dosages | Pharmacy | Potassium | Pharmaceuticals | Titanium dioxide nanoparticles (TNP) | Physiosorption | Azithromycin (AZ) | Azithromycin- TiO2 Nanohybrid (AZN)
Journal Article
Journal Article